Shares of Mobileye Global climbed after the company agreed to acquire artificial-intelligence robotics startup Mentee Robotics for $900 million. The stock gained 11%, to $13.55, in after-hours trading ...
Monte Rosa Therapeutics said it will host a call to review results from an early-stage trial of its treatment of inflammatory diseases. The presentation is scheduled for 8 a.m. EST on Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback